Accountable Care OrganizationsAmbulatory Procedure/Imaging CenterAmbulatory/Office-based CareAncillary ServicesAssisted Living FacilitiesBehavioral Health CareCommunity Health CareEmergency DepartmentEmergency Medical ServicesHome CareHospicesHospital InpatientHospital OutpatientHospital â OtherIntensive Care UnitsLong-term Care Facilities - OtherManaged Care PlansNational Public Health ProgramsOtherPatient-centered Medical HomesRegional, County, or City Public Health ProgramsRehabilitation CentersResidential Care FacilitiesRural Health CareSkilled Nursing Facilities/Nursing HomesState/Provincial Public Health ProgramsSubstance Use Treatment Programs/CentersTransitionUnspecified
Hepatopancreatobiliary (HPB) cancer: proportion of patients with pancreatic, duodenal, or distal biliary tract cancer undergoing surgical resection who die within 30 and 90 days.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Hepatopancreatobiliary (HPB) cancer: proportion of patients who undergo resection for pancreatic, duodenal, or distal biliary tract cancer.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Hepatopancreatobiliary (HPB) cancer: proportion of patients undergoing resection for pancreatic cancer who receive adjuvant chemotherapy.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Hepatopancreatobiliary (HPB) cancer: proportion of patients with pancreatic, duodenal or distal biliary tract cancer undergoing non-surgical treatment who have a histological or cytological diagnosis.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Hepatopancreatobiliary (HPB) cancer: proportion of patients with pancreatic, duodenal or biliary tract cancer who undergo CT of the chest, abdomen and pelvis.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Hepatopancreatobiliary (HPB) cancer: proportion of patients with hepatocellular carcinoma (HCC) undergoing disease specific treatment with curative intent (liver transplant, resection, or ablation) who die within 90 days of definitive treatment.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Hepatopancreatobiliary (HPB) cancer: proportion of patients with hepatocellular carcinoma (HCC) undergoing disease specific treatment (liver transplant, resection, ablation, trans-arterial chemoembolisation ) who die within 30 days of definitive treatment.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Hepatopancreatobiliary (HPB) cancer: proportion of patients with hepatocellular carcinoma (HCC) not undergoing treatment with curative intent (liver transplantation, resection or ablative therapies) who receive trans-arterial chemoembolisation (TACE) or approved systemic anti-cancer therapy (SACT).
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Hepatopancreatobiliary (HPB) cancer: proportion of patients with hepatocellular carcinoma (HCC) who meet the current UK listing criteria for liver transplantation who are referred to the Scottish Liver Transplant Unit (SLTU).
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Hepatopancreatobiliary (HPB) cancer: proportion of patients with hepatocellular carcinoma (HCC) undergoing either CT or MRI and with full information recorded.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Hepatopancreatobiliary (HPB) cancer: proportion of patients with HPB cancer who are discussed at a multidisciplinary team (MDT) meeting before definitive treatment.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Upper gastrointestinal (GI) cancer: proportion of patients with oesophageal or gastric cancer who undergo surgical resection in which longitudinal surgical margin is clear of tumour (i.e., negative surgical margin).
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Cancer patient experience: percentage of patients who reported whether they have been enabled by healthcare professionals to share decisions about their care and treatment on the Cancer Quality Performance Indicator (QPI) Shared Decision Making Measurement Tool.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Cancer patient experience: percentage of patients who reported whether they experienced excellent information provision from healthcare professionals throughout their cancer care on the Cancer Quality Performance Indicator (QPI) Information Measurement Tool.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Cancer patient experience: percentage of patients who reported whether they experienced excellent communication from healthcare professionals throughout their cancer care on the Cancer Quality Performance Indicator (QPI) Communication Measurement Tool.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Cervical cancer: proportion of patients with cervical cancer undergoing radical radiotherapy who receive concurrent chemotherapy.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Cervical cancer: proportion of patients with cervical cancer undergoing radical radiotherapy (external beam or brachytherapy) whose overall treatment time, from start to the end of treatment, is not more than 56 days.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Cervical cancer: proportion of patients with cervical cancer who are discussed at a multidisciplinary team (MDT) meeting before definitive treatment.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Cervical cancer: proportion of patients with cervical cancer undergoing primary radical radiotherapy who have PET/CT imaging prior to starting treatment.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Cervical cancer: proportion of patients with cervical cancer who have an MRI of the pelvis performed prior to definitive treatment.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
